The Korea-based company CGBIO Inc. has announced a partnership agreement with Singapore-based company NDR Medical Technology to release an Automated Needle Targeting (ANT)-X system with Artificial Intelligence (AI) and medical image processing. This device will collaborate in clinical study aid and assist surgeons during minimally invasive surgery.

The signing ceremony was attended by a government official from Enterprise Singapore, and CGBIO expects that this partnership will help promote mutual medical technology collaboration between Singapore and Korea as well as extend its globalization strategy of local medical technology in the future.

Hyunseung Yu, CEO of CGBIO, said, “Many global medical device companies have endeavored to be partnering with top candidates for AI software-based digital transformation. Based on the accumulated Regenerative Medicine technology and numerous clinical experiences hitherto, CGBIO and NDR together will explore the field of AI-based digital healthcare technology in Asia. Through our commitment to providing reliable and accurate medical services to patients, we count on stronger business competitiveness in the global digital healthcare market.”

Through its partnership with NDR, CGBIO will develop a range of interventions and treatments involving percutaneous needs that will be evaluated among leading local doctors and will finalize the launch of the CT-guided ANT-C.

Nanyang Technology graduates founded NDR Medical Technology in 2015, developing the world’s first AI-powered interventional robot system.

Most clinicians to date conduct their interventional procedures based on a separate program meant to assess a patient’s anatomy and conduct path alignment of the needle’s trajectory between the insertion point and target. This method is insufficiently precise and takes a long time to complete.

As part of its technology, NDR’s ANT system relies on CT imaging and fluoroscopy to assist clinicians in accurately placing percutaneous needles using NDR’s first interventional robot. Through the use of a single X-ray image, ANT-X’s system calibration and needle alignment are completely automated, allowing clinicians to focus solely on controlling the depth of insertion. Because of accurate and quick needle alignment, patients and clinicians are exposed to less radiation. ANT-X has been CE-certified by NDR, and clinical studies have been completed in Japan and Southeast Asia.